510(k) K091260

SERAQUEST EBV EA-D IGG TEST by Quest Intl., Inc. — Product Code LSE

K091260 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "SERAQUEST EBV EA-D IGG TEST". The FDA issued a decision of Substantially Equivalent on June 8, 2009. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Quest Intl., Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 8, 2009
Date Received
April 29, 2009
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type